4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001104659-24-042776
Options or other derivatives
- Chief Medical Officer acquired 47,088 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Deliargyris Efthymios Chief Medical Officer | 2024-03-29 | Grant or award · Stock Option (Right to Buy) | +47,088 | 47,088 | D | ||
Loading xslF345X05/tm2410664-4_4seq1.xml…